219 related articles for article (PubMed ID: 35105853)
1. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.
Gai QJ; Fu Z; He J; Mao M; Yao XX; Qin Y; Lan X; Zhang L; Miao JY; Wang YX; Zhu J; Yang FC; Lu HM; Yan ZX; Chen FL; Shi Y; Ping YF; Cui YH; Zhang X; Liu X; Yao XH; Lv SQ; Bian XW; Wang Y
Signal Transduct Target Ther; 2022 Feb; 7(1):33. PubMed ID: 35105853
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.
Boonjaraspinyo S; Boonmars T; Wu Z; Loilome W; Sithithaworn P; Nagano I; Pinlaor S; Yongvanit P; Nielsen PS; Pairojkul C; Khuntikeo N
Tumour Biol; 2012 Oct; 33(5):1785-802. PubMed ID: 22733151
[TBL] [Abstract][Full Text] [Related]
3. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.
Peng G; Wang Y; Ge P; Bailey C; Zhang P; Zhang D; Meng Z; Qi C; Chen Q; Chen J; Niu J; Zheng P; Liu Y; Liu Y
J Exp Clin Cancer Res; 2021 Sep; 40(1):278. PubMed ID: 34470658
[TBL] [Abstract][Full Text] [Related]
4. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations.
Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS
Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192
[TBL] [Abstract][Full Text] [Related]
5. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
Martinho O; Longatto-Filho A; Lambros MB; Martins A; Pinheiro C; Silva A; Pardal F; Amorim J; Mackay A; Milanezi F; Tamber N; Fenwick K; Ashworth A; Reis-Filho JS; Lopes JM; Reis RM
Br J Cancer; 2009 Sep; 101(6):973-82. PubMed ID: 19707201
[TBL] [Abstract][Full Text] [Related]
6. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
Wykosky J; Gibo DM; Stanton C; Debinski W
Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
[TBL] [Abstract][Full Text] [Related]
7. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis.
Kartha RV; Sundram UN
Mod Pathol; 2008 Feb; 21(2):96-104. PubMed ID: 18084259
[TBL] [Abstract][Full Text] [Related]
8. Co-amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma.
Wang H; Wang X; Xu L; Zhang J
Cancer Med; 2023 Feb; 12(4):4951-4967. PubMed ID: 36043552
[TBL] [Abstract][Full Text] [Related]
9. A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion.
Gopal U; Bohonowych JE; Lema-Tome C; Liu A; Garrett-Mayer E; Wang B; Isaacs JS
PLoS One; 2011 Mar; 6(3):e17649. PubMed ID: 21408136
[TBL] [Abstract][Full Text] [Related]
10. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
Silber J; Jacobsen A; Ozawa T; Harinath G; Pedraza A; Sander C; Holland EC; Huse JT
PLoS One; 2012; 7(3):e33844. PubMed ID: 22479456
[TBL] [Abstract][Full Text] [Related]
11. Bone Morphogenic Protein 4-Smad-Induced Upregulation of Platelet-Derived Growth Factor AA Impairs Endothelial Function.
Hu W; Zhang Y; Wang L; Lau CW; Xu J; Luo JY; Gou L; Yao X; Chen ZY; Ma RC; Tian XY; Huang Y
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):553-60. PubMed ID: 26769046
[TBL] [Abstract][Full Text] [Related]
12. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
13. PDGF-A signaling is required for secondary alveolar septation and controls epithelial proliferation in the developing lung.
Gouveia L; Betsholtz C; Andrae J
Development; 2018 Apr; 145(7):. PubMed ID: 29636361
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis.
Goenka A; Song X; Tiek D; Iglesia RP; Lu M; Zeng C; Horbinski C; Zhang W; Hu B; Cheng SY
Neuro Oncol; 2023 Sep; 25(9):1592-1604. PubMed ID: 36988488
[TBL] [Abstract][Full Text] [Related]
15. EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines.
Chakravarty D; Pedraza AM; Cotari J; Liu AH; Punko D; Kokroo A; Huse JT; Altan-Bonnet G; Brennan CW
Sci Rep; 2017 Aug; 7(1):9043. PubMed ID: 28831081
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog and Platelet-derived Growth Factor Signaling Intersect during Postnatal Lung Development.
Yie TA; Loomis CA; Nowatzky J; Khodadadi-Jamayran A; Lin Z; Cammer M; Barnett C; Mezzano V; Alu M; Novick JA; Munger JS; Kugler MC
Am J Respir Cell Mol Biol; 2023 May; 68(5):523-536. PubMed ID: 36693140
[TBL] [Abstract][Full Text] [Related]
17. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
18. PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.
Xu R; Ji J; Zhang X; Han M; Zhang C; Xu Y; Wei Y; Wang S; Huang B; Chen A; Zhang D; Zhang Q; Li W; Jiang Z; Wang J; Li X
J Exp Clin Cancer Res; 2017 Dec; 36(1):193. PubMed ID: 29282077
[TBL] [Abstract][Full Text] [Related]
19. KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis.
Cavallin LE; Ma Q; Naipauer J; Gupta S; Kurian M; Locatelli P; Romanelli P; Nadji M; Goldschmidt-Clermont PJ; Mesri EA
PLoS Pathog; 2018 Jul; 14(7):e1007175. PubMed ID: 29985958
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
